Miguel Bernardes

Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry

Jeffrey A. Sparks, Zachary S. Wallace, Andrea M. Seet et al. · Annals of the Rheumatic Diseases · 2021 · 236 citations · Full text

Classification of Systemic Lupus Erythematosus: Systemic Lupus International Collaborating Clinics Versus American College of Rheumatology Criteria. A Comparative Study of 2,055 Patients From a Real‐Life, International Systemic Lupus Erythematosus Cohort

Luís Inês, María Galindo-Izquierdo, Francisco Javier López-Longo et al. · Arthritis Care & Research · 2015 · 154 citations · Full text

Depression and anxiety in systemic lupus erythematosus

Margarida Figueiredo‐Braga, Caleb Cornaby, A. Cortez et al. · Medicine · 2018 · 122 citations · Full text

Rheumatology, Psychoneuroimmunology, Systemic Lupus Erythematosus +15

Quality of life and functional capacity in patients with rheumatoid arthritis – Cross-sectional study

D. Rosa-Gonçalves, Miguel Bernardes, Lúcia Costa · Reumatología Clínica · 2017 · 65 citations

Rheumatoid Disorder, Rheumatology, Quality Of Life +8

SLC19A1, SLC46A1 and SLCO1B1 Polymorphisms as Predictors of Methotrexate-Related Toxicity in Portuguese Rheumatoid Arthritis Patients

Áurea Lima, Miguel Bernardes, Rita Azevedo et al. · Toxicological Sciences · 2014 · 61 citations · Full text

Genetic Epidemiology, Human Polymorphism, Pathology +19